ACM
JNJ icon

Aljian Capital Management’s Johnson & Johnson JNJ Stock Holding History

Aljian Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$863K Sell
3,400
-7
-0.2% -$1.63K 0.16% 69
2026
Q1 		$833K Buy
3,407
+5
+0.1% +$1.17K 0.17% 65
2025
Q4 		$704K Buy
3,402
+7
+0.2% +$1.38K 0.14% 73
2025
Q3 		$630K Sell
3,395
-2
-0.1% -$343 0.13% 79
2025
Q2 		$519K Sell
3,397
-62
-2% -$9.53K 0.11% 82
2025
Q1 		$574K Sell
3,459
-59
-2% -$9.23K 0.14% 80
2024
Q4 		$509K Buy
3,518
+19
+0.5% +$2.94K 0.11% 78
2024
Q3 		$567K Buy
+3,499
New +$557K 0.13% 74
2023
Q3 		– Sell
-1,837
Closed -$304K – 41
2023
Q2 		$304K Sell
1,837
-875
-32% -$141K 0.14% 38
2023
Q1 		$420K Sell
2,712
-215
-7% -$34.7K 0.21% 34
2022
Q4 		$517K Buy
2,927
+46
+2% +$7.94K 0.3% 32
2022
Q3 		$473K Sell
2,881
-95
-3% -$16.1K 0.26% 32
2022
Q2 		$527K Sell
2,976
-72
-2% -$12.8K 0.29% 31
2022
Q1 		$547K Sell
3,048
-226
-7% -$38.5K 0.22% 35
2021
Q4 		$560K Sell
3,274
-210
-6% -$34.4K 0.21% 38
2021
Q3 		$566K Sell
3,484
-163
-4% -$27.8K 0.25% 35
2021
Q2 		$601K Sell
3,647
-195
-5% -$32.3K 0.26% 36
2021
Q1 		$632K Sell
3,842
-68
-2% -$11K 0.3% 36
2020
Q4 		$615K Buy
3,910
+130
+3% +$19.2K 0.31% 33
2020
Q3 		$561K Buy
3,780
+80
+2% +$11.8K 0.31% 32
2020
Q2 		$348K Sell
3,700
-75
-2% -$10.9K 0.22% 33
2020
Q1 		$495K Sell
3,775
-150
-4% -$21.3K 0.41% 29
2019
Q4 		$573K Sell
3,925
-190
-5% -$25.8K 0.43% 30
2019
Q3 		$532K Sell
4,115
-680
-14% -$89.6K 0.44% 30
2019
Q2 		$668K Sell
4,795
-41
-0.8% -$5.67K 0.55% 29
2019
Q1 		$676K Buy
4,836
+185
+4% +$24.8K 0.57% 30
2018
Q4 		$600K Buy
+4,651
New +$649K 0.6% 30

Other funds holding JNJ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Aljian Capital Management's JNJ Position: Q2 2026 in Review

Aljian Capital Management reduced its Johnson & Johnson (JNJ) stake by 0.21% in Q2 2026, selling an estimated $1.63K and leaving 3,400 shares worth $863K. The position accounts for 0.16% of the portfolio, ranked #69.

Aljian Capital Management first reported a position in JNJ in Q4 2018 and has held it in 27 quarters since. 4,685 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Aljian Capital Management held 3,400 shares of Johnson & Johnson worth $863K as of Q2 2026.
  • Aljian Capital Management sold 7 Johnson & Johnson shares in Q2 2026, an estimated $1.63K.
  • Johnson & Johnson made up 0.16% of Aljian Capital Management's portfolio in Q2 2026, its #69 holding.
  • Aljian Capital Management first reported a position in Johnson & Johnson in Q4 2018 and has held it in 27 quarters since.
  • 4,685 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Aljian Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.